These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2254382)

  • 1. Adriamycin uptake and metabolism in organotypic culture of A549 human adenocarcinoma cells according to the exposure time.
    Chevillard S; Vielh P; Bastian G; Coppey J
    J Cancer Res Clin Oncol; 1990; 116(6):633-8. PubMed ID: 2254382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects and pharmacokinetic analysis of combined adriamycin and X-ray treatments in human organotypic cell cultures.
    Chevillard S; Vielh P; Campana F; Bastian G; Coppey J
    Anticancer Drugs; 1992 Apr; 3(2):133-7. PubMed ID: 1525390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of adriamycin in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1987 Jun; 36(11):1793-8. PubMed ID: 3579974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection.
    Pierce RN; Jatlow PI
    J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New data on the pharmacokinetics of adriamycin and its major metabolite, adriamycinol.
    Leca F; Marchiset-Leca D; Noble A; Antonetti M
    Eur J Drug Metab Pharmacokinet; 1991; 16(2):107-11. PubMed ID: 1936069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin metabolism in man. Evidence from urinary metabolites.
    Takanashi S; Bachur NR
    Drug Metab Dispos; 1976; 4(1):79-87. PubMed ID: 3405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
    Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
    BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative intracellular uptake of adriamycin and 4'-deoxydoxorubicin by non-small cell lung tumor cells in culture and its relationship to cell survival.
    Kerr DJ; Kerr AM; Freshney RI; Kaye SB
    Biochem Pharmacol; 1986 Aug; 35(16):2817-23. PubMed ID: 3741470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of doxorubicin on the glutathione content and viability of cultured human lung cancer cell lines A549 and GLC4 210.
    al-Kabban M; Stewart MJ; Watson ID; Reglinski J
    Clin Chim Acta; 1990 Dec; 194(2-3):121-9. PubMed ID: 1965536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilary disposition of adriamycin.
    Riggs CE; Benjamin RS; Serpick AA; Bachur NR
    Clin Pharmacol Ther; 1977 Aug; 22(2):234-41. PubMed ID: 884924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat.
    Han G; Israel M; Seshadri R; Dalton JT; Sweatman TW
    Cancer Chemother Pharmacol; 1996; 37(5):472-8. PubMed ID: 8599871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress.
    Maryam A; Mehmood T; Zhang H; Li Y; Khan M; Ma T
    Sci Rep; 2017 Jul; 7(1):6242. PubMed ID: 28740138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS; Riggs CE; Bachur NR
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical model for adriamycin (doxorubicin) pharmacokinetics.
    Reich SD; Steinberg F; Bachur NR; Riggs CE; Goebel R; Berman M
    Cancer Chemother Pharmacol; 1979; 3(2):125-31. PubMed ID: 509697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography.
    Shinozawa S; Mimaki Y; Araki Y; Oda T
    J Chromatogr; 1980 Aug; 196(3):463-9. PubMed ID: 7430305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines.
    Farhane Z; Bonnier F; Byrne HJ
    Anal Bioanal Chem; 2017 Feb; 409(5):1333-1346. PubMed ID: 27888307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytofluorescence localization of adriamycin in resistant colon cancer cells.
    Chauffert B; Martin F; Caignard A; Jeannin JF; Leclerc A
    Cancer Chemother Pharmacol; 1984; 13(1):14-8. PubMed ID: 6733840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin accumulation and metabolism in adriamycin-sensitive and -resistant human ovarian cancer cell lines.
    Louie KG; Hamilton TC; Winker MA; Behrens BC; Tsuruo T; Klecker RW; McKoy WM; Grotzinger KR; Myers CE; Young RC
    Biochem Pharmacol; 1986 Feb; 35(3):467-72. PubMed ID: 3947382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature dependence studies of adriamycin uptake and cytotoxicity.
    Lane P; Vichi P; Bain DL; Tritton TR
    Cancer Res; 1987 Aug; 47(15):4038-42. PubMed ID: 3607749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin uptake, intracellular binding and cytotoxicity in Chinese hamster ovary cells.
    Bates DA; Fung H; Mackillop WJ
    Cancer Lett; 1985 Sep; 28(2):213-21. PubMed ID: 4052991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.